Atlas Trials

A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

Clinical trial NCT05947838 · RECRUITING

Trial details

NCT number
NCT05947838
Sponsor
M.D. Anderson Cancer Center
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Appendiceal AdenocarcinomaColorectal
Start date
2023-12-04
Primary completion
2027-04-30
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.